Researchers analyzed a key protein from the two bird flu viruses, variants of subtypes H10N8 and H6N1. They found the strains haven’t acquired the changes necessary that would allow them to infect humans easily and cause a pandemic.
However, that does not mean the world is safe from a bird flu pandemic, warned Ian A. Wilson, PhD, a professor and chair of TSRI’s Department of Integrative Structural and Computational Biology. “These bird flu viruses seem able to bind to receptors on host cells in different ways and thus can probably mutate in different ways to jump to humans — so we shouldn’t be complacent in our ability to predict the viral changes required to get a pandemic,” he said.
The research is presented in two papers in the journal Cell Host & Microbe.
More articles on the flu:
Flu continues its decline in the US
Kansas State University begins preparing for next flu strain
Seasonal flu vaccine protects against avian flu
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
